top of page

Solutions
Industries
Advanced Therapy Medicinal Products (ATMP) & Cell and Gene Therapies (CGT)
Overview
Advanced Therapy Medicinal Products (ATMP) and Cell and Gene Therapies (CGT) offer groundbreaking new opportunities for treating diseases and injuries using genes, tissues, or cells. Unlike traditional pharmaceutical facilities, which use closed and automated processes to manufacture high-volume batches of identical products, ATMP/CGT manufacturing is primarily a small-batch, operator-driven process.
To achieve efficient and cost-effective production, facilities must be flexible. This includes the ability to produce multiple products within the same facility and quickly adapt and integrate new technologies and processes. The critical endpoint in this complex process cycle for cell and gene therapy is packaging the liquid medicinal product into vials, syringes, or IV bags.
Our Vers-A-Tech™ machine meets the needs of ATMP and Cell and Gene Therapy processing. This innovative semi- or fully-automatic fill-finish line is designed to accelerate the packaging of bags and nested containers on one platform.

BioTechnology
Overview
Biopharmaceutical companies continue to focus on developing high-value, targeted therapies for smaller patient populations. Manufacturing operations are being re-engineered to meet the growing demands for producing small batches of precision medicines. Key trends in this segment include:
- Implementing continuous flow systems to enhance
time efficiency, reduce costs, and ensure patient and
product safety
- Increasing the use of single-use systems to minimize
the risk of cross-contamination and decrease
equipment downtime for cleaning
- Boosting flexibility to manufacture multiple products
simultaneously, allowing for smaller batch sizes and
rapid changeovers
The packaging requirements for biotech are complex, but we have the right solution for you. Our modular components are custom integrated to your specifications, featuring single-use fluid pathway kits, toolless change-over parts for various container sizes and types, and automation to safely process repetitive tasks.

Pharmaceuticals
Overview
The global pharmaceutical industry is experiencing increasing demand for proven vaccines and medicines, as well as a growing need for self-administered treatments via pre-filled syringes, auto-injectors, and wearable devices. Additionally, talent shortages and new treatment modalities are significantly impacting the manufacturing of these critical medicines.
Our fill-finish solutions are constantly evolving to adapt to the dynamic requirements of the pharmaceutical industry and, most importantly, to support our customers' operations. We collaborate closely with each client to overcome specific challenges and optimize their packaging processes. With 55 years of experience, we have successfully served a wide range of clients with varying needs in the pharmaceutical sector.
By integrating modular processing components, our solutions offer the flexibility to meet future demands and incorporate automation to ensure product safety and address labor shortages.

503B Manufacturing
Overview
The compounding industry is expanding rapidly in response to ongoing drug shortages and rising drug costs. 503B Outsourcing Facilities are increasing their processing capacity to meet the growing demand for ready-to-administer sterile compounded medicines. These facilities face complex processing requirements and need flexibility to handle various batch sizes and multiple products.

Advanced Therapy Medicinal Products (ATMP) & Cell and Gene Therapies (CGT)

Overview
Advanced Therapy Medicinal Products (ATMP) and Cell and Gene Therapies (CGT) offer groundbreaking new opportunities for treating diseases and injuries using genes, tissues, or cells. Unlike traditional pharmaceutical facilities, which use closed and automated processes to manufacture high-volume batches of identical products, ATMP/CGT manufacturing is primarily a small-batch, operator-driven process.

Overview
Biopharmaceutical companies continue to focus on developing high-value, targeted therapies for smaller patient populations. Manufacturing operations are being re-engineered to meet the growing demands for producing small batches of precision medicines. Key trends in this segment include:
- Implementing continuous flow
systems to enhance time
efficiency, reduce costs, and
ensure patient and product
safety
- Increasing the use of single
use systems to minimize the
risk of cross-contamination
and decrease equipment
downtime for cleaning
- Boosting flexibility to
manufacture multiple
products simultaneously,
allowing for smaller batch
sizes and rapid changeovers
The packaging requirements for biotech are complex, but we have the right solution for you. Our modular components are custom integrated to your specifications, featuring single-use fluid pathway kits, toolless change-over parts for various container sizes and types, and automation to safely process repetitive tasks.
Industries We Serve
Pharmaceuticals

Overview
The global pharmaceutical industry is experiencing increasing demand for proven vaccines and medicines, as well as a growing need for self-administered treatments via pre-filled syringes, auto-injectors, and wearable devices. Additionally, talent shortages and new treatment modalities are significantly impacting the manufacturing of these critical medicines.
Our fill-finish solutions are constantly evolving to adapt to the dynamic requirements of the pharmaceutical industry and, most importantly, to support our customers' operations. We collaborate closely with each client to overcome specific challenges and optimize their packaging processes. With 55 years of experience, we have successfully served a wide range of clients with varying needs in the pharmaceutical sector.
By integrating modular processing components, our solutions offer the flexibility to meet future demands and incorporate automation to ensure product safety and address labor shortages.
BioTechnology

Overview
The compounding industry is expanding rapidly in response to ongoing drug shortages and rising drug costs. 503B Outsourcing Facilities are increasing their processing capacity to meet the growing demand for ready-to-administer sterile compounded medicines. These facilities face complex processing requirements and need flexibility to handle various batch sizes and multiple products.
503B
Manufacturing
bottom of page